2001
DOI: 10.1162/152651601300169077
|View full text |Cite
|
Sign up to set email alerts
|

Participation as Commodity, Participation as Gift

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 2 publications
0
11
0
Order By: Relevance
“…These local level debates echo elements of international benefit sharing and ancillary care debates [ 10 , 33 ], and of recent debates among researchers at the Programme [ 22 ]. Some argue that research and research participation should primarily be based on goodwill, altruism, and partnership, and aim to avoid costs to participants and a commercial relationship [ 13 , 34 , 35 ]. Others argue that research should maximise participants’ benefits given the relative wealth of the research institution and multiple community needs [ 10 , 36 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…These local level debates echo elements of international benefit sharing and ancillary care debates [ 10 , 33 ], and of recent debates among researchers at the Programme [ 22 ]. Some argue that research and research participation should primarily be based on goodwill, altruism, and partnership, and aim to avoid costs to participants and a commercial relationship [ 13 , 34 , 35 ]. Others argue that research should maximise participants’ benefits given the relative wealth of the research institution and multiple community needs [ 10 , 36 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Second, the ethics of monetary payments in research are hotly debated within the broader bioethics literature (e.g., Lemmens & Elliot, 1999;Chambers, 2001;Grady, 2001;Moreno, 2001;Todd, 2001;Vanderpool, 2001), and specific concerns have been raised about the use of financial incentives in research with drug users. Key issues identified include the idea that such payments jeopardize informed consent by acting as an undue inducement, exploiting drug users' economic vulnerability and marginalization; some have also argued that paying drug users encourages and rewards illicit drug use (Fry & Dwyer, 2001;Buchanan et al, 2002;Ritter, Fry, & Swan, 2003;Sheldon, 2005;Fry et al, 2005Fry et al, , 2006.…”
mentioning
confidence: 99%
“…10. Chambers (2001) argues that paying for research participation is wrong because it turns the gift of participation into a commodity. Kuczewski (2001) argues against paying for research participation because he believes this would endanger the professional integrity of biomedical research.…”
Section: Disclosure Statementmentioning
confidence: 99%